Scan to downloadTOWA PHARMACEUTICAL CO.,LTD. (4553) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-11-11 | — | Notice of Recognition of a Non-Operating Expense (Loss on Valuation of Derivatives) | |
| 2026-11-11 | Earnings Release | Consolidated Financial Results for the Six Months Ended September 30, 2026 (Based on Japanese GAAP) | |
| 2026-11-11 | Earnings Release | Supplementary material for the financial results for the second quarter (interim period) of the year ending March 31, 2027 | |
| 2026-10-30 | — | (Change in Disclosure Information) Notice of Change in the Date of Execution of the Share Transfer Concerning the Acquisition of Shares | |
| 2026-08-06 | Earnings Release | Consolidated Financial Results for the Three Months Ended June 30, 2026 (Based on Japanese GAAP) | |
| 2026-08-06 | Earnings Release | Supplementary material for the financial results for the first quarter of the year ending March 31, 2027 | |
| 2026-07-31 | — | Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.